Asthma Tied to Increased Risk of Chronic Migraines

This article originally appeared here.
Share this content:
Asthma Tied to Increased Risk of Chronic Migraines
Asthma Tied to Increased Risk of Chronic Migraines

FRIDAY, Dec. 11, 2015 (HealthDay News) -- People with asthma may be more than twice as likely to develop chronic migraines as those without asthma, according to a study published online Nov. 19 in Headache.

The research included 4,446 Americans. At the start of the study in 2008, the study volunteers had fewer than 15 migraines a month. One year later, the researchers looked to see how many had chronic migraine, defined as 15 or more migraines a month.

More than 5 percent of people with asthma developed chronic migraine, compared to 2.5 percent of those without. The lead author Vincent Martin, M.D., a professor of medicine and co-director of the Headache and Facial Pain Program at the University of Cincinnati, said in a university news release that having asthma was an even stronger predictor of chronic migraines than depression.

"Migraine and asthma are disorders that involve inflammation and activation of smooth muscle either in blood vessels or in the airways," study coauthor Richard Lipton, M.D., director of Montefiore Headache Center in New York City, said in the news release. "Therefore, asthma-related inflammation may lead to migraine progression."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »